Cynosure Management, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Cynosure Management, LLC
- $680 Million
- Q3 2024
A detailed history of Cynosure Management, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Cynosure Management, LLC holds 7,426 shares of AMPH stock, worth $335,580. This represents 0.05% of its overall portfolio holdings.
Number of Shares
7,426
Previous 9,276
19.94%
Holding current value
$335,580
Previous $371,000
2.96%
% of portfolio
0.05%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding AMPH
# of Institutions
287Shares Held
35.1MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$269 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$123 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$96.5 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$88 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$73 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.21B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...